We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF

194 hedge funds and large institutions have $658M invested in iShares US Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 64 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 13

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

73% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 37

19% more capital invested

Capital invested by funds: $551M → $658M (+$107M)

9% more funds holding

Funds holding: 178194 (+16)

1.19% more ownership

Funds ownership: 64.92%66.11% (+1.2%)

Holders
194
Holders Change
+16
Holders Change %
+8.99%
% of All Funds
2.39%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
34
Increased
64
Reduced
37
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
201
Axxcess Wealth Management
California
-$769K -9,062 Closed
SWA
202
Stratos Wealth Advisors
Ohio
-$555K -6,546 Closed
GCP
203
GSA Capital Partners
United Kingdom
-$216K -2,547 Closed
AP
204
Advisors Preferred
Maryland
-$140K -1,655 Closed
EI
205
EFG International
-$37.9K -447 Closed
Citigroup
206
Citigroup
New York
-$36.7K -433 Closed
FHA
207
Flagship Harbor Advisors
Massachusetts
-$1.85K -21 Closed
NWS
208
Nvest Wealth Strategies
Ohio
-$1.27K -15 Closed